Mechanisms of endothelial dysfunction in obesity

被引:137
作者
Avogaro, A [1 ]
de Kreutzenberg, SV [1 ]
机构
[1] Univ Padua, Dept Clin & Expt Med, Sch Med, I-35128 Padua, Italy
关键词
endothelium; endothelial dysfunction; adipose tissue; obesity;
D O I
10.1016/j.cccn.2005.04.020
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Obesity is a chronic disease, whose incidence is alarmingly growing, affecting not only adults but also children and adolescents. It is associated with severe metabolic abnormalities and increased cardiovascular morbidity and mortality. Adipose tissue secretes a great number of hormones and cytokines that not only regulate substrate metabolism but may deeply and negatively influence endothelial physiology, a condition which may lead to the formation of the atherosclerotic plaque. In this review, the physiology of the endothelium is summarised and the mechanisms by which obesity, through the secretory products of adipose tissue, influences endothelial function are explained. A short description of methodological approaches to diagnose or endothelial dysfunction is presented. The possible pathogenetic links between obesity and cardiovascular disease, mediated by oxidative stress, inflammation and endothelial dysfunction are described as well. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:9 / 26
页数:18
相关论文
共 154 条
[1]   Insulin resistance and obesity - The role of fat distribution pattern [J].
Abate, N .
DIABETES CARE, 1996, 19 (03) :292-294
[2]   Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries [J].
Al Suwaidi, J ;
Higano, ST ;
Holmes, DR ;
Lennon, R ;
Lerman, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (06) :1523-1528
[3]   Association between obesity and coronary atherosclerosis and vascular remodeling [J].
Al Suwaidi, J ;
Higano, ST ;
Hamasaki, S ;
Holmes, DR ;
Lerman, A .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (11) :1300-+
[4]   Tumor necrosis factor-α inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells [J].
Aljada, A ;
Ghanim, H ;
Assian, E ;
Dandona, P .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (04) :487-491
[5]   Tumor necrosis factor-α inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells [J].
Anderson, HDI ;
Rahmutula, D ;
Gardner, DG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (02) :963-969
[6]   Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction [J].
Anderson, TJ .
HEART FAILURE REVIEWS, 2003, 8 (01) :71-86
[7]   Assessment and treatment of endothelial dysfunction in humans [J].
Anderson, TJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (03) :631-638
[8]   Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity [J].
Arcaro, G ;
Zamboni, M ;
Rossi, L ;
Turcato, E ;
Covi, G ;
Armellini, F ;
Bosello, O ;
Lechi, A .
INTERNATIONAL JOURNAL OF OBESITY, 1999, 23 (09) :936-942
[9]   Monocyte NADPH oxidase subunit p22phox and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients:: Relationship with oxidative stress [J].
Avogaro, A ;
Pagnin, E ;
Calò, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04) :1753-1759
[10]   L-arginine-nitric oxide kinetics in nonnal and type 2 diabetic subjects -: A stable-labelled 15N arginine approach [J].
Avogaro, A ;
Toffolo, G ;
Kiwanuka, E ;
de Kreutzenberg, SV ;
Tessari, P ;
Cobelli, C .
DIABETES, 2003, 52 (03) :795-802